• careers
  • investors
  • news
  • suppliers
  • alumni
  • login
  • worldwide
    • Argentina
    • Australia
    • Austria
    • Belgium
    • Brazil
    • Canada
    • Chile
    • China
    • Colombia
    • Costa Rica
    • Denmark
    • Ecuador
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • India
    • Ireland
    • Italy
    • Japan
    • Korea
    • Latin America
    • Mexico
    • Netherlands
    • Norway
    • Peru
    • Philippines
    • Russia
    • Singapore
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan
    • Turkey
    • United Kingdom
    • Venezuela

Eli Lilly and Company

Eli Lilly and Company

  • home
  • about

    About

    Heritage
    Key Facts
    Global Business Areas
    Board of Directors
    Executives
    Corporate Governance
    Business Practices
    Key Issues
    Diversity
    Lilly Foundation
    Lilly Grant Office

    The 10th largest pharmaceutical company in the world, Lilly has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. At the heart of Lilly's operations are its core values - excellence, integrity and respect for people.

    Lilly is about more than creating medicines.

    Key Facts Diversity
  • responsibility

    Responsibility

    Our Approach
    Ethical Business
    Access to Medicines
    Medicine Development
    Workplace
    Communities
    Patients
    Environmental Sustainability

    How Lilly conducts its business is equally as important as the work it does on a daily basis. Lilly's core values - integrity, excellence and respect for people - are reflected in business practices that include strong governance principles, the ethical development of medicines, transparency and ethical product promotion.

    Responsibility is not a fad. It is at the core of who we are.

    Connecting Hearts Abroad Access to Medcines
  • products

    Products

    Human
    Animal
    Patient Safety
    Anti-Counterfeiting

    Lilly's innovative products focus on meeting medical needs in the fields of oncology, cardiovascular, diabetes, critical care, neuroscience, men's health and musculoskeletal. Additionally, Elanco, a division of Eli Lilly and Company, works to provide an equally high standard of quality care and product development for animals.

    Our products help shape diabetes care worldwide.

    Safety Anti-Counterfeiting
  • r & d

    R & D

    Approach to R&D
    Open Innovation
    Innovation Starts Here
    Global External R&D
    Partnering

    More than 7,300 people comprise Lilly Research Laboratories (LRL), which operates in more than 50 countries worldwide. LRL works to discover and develop innovative therapies for many of the world's unmet medical needs, while also providing ongoing scientific support for marketed products.

    Research is the backbone of Lilly.

    Bioethics Our Pipeline
 

News

 

Current News Headlines

TODAY'S DATE: May 16, 2012

May 14, 2012

Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer

May 14, 2012

Lilly Oncology To Disclose New Pipeline Data At ASCO 2012

May 3, 2012

Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center

May 3, 2012

Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community

April 25, 2012

DiversityInc Names Lilly a Top Company for Diversity

April 25, 2012

Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises EPS Guidance

Media Kit


MEDIA
KIT
Access Available Media Kit
Images



IMAGERY
Download Imagery for Media Usage
Corporate News
Financial News
Product News
Corporate Responsibility News
Speeches & Presentations
Press Release Archives
Media Center

Search News



News Tools


  • Sign up for Email Alerts
  • Briefcase
  • Sign up for RSS Feeds

Copyright © Eli Lilly and Company. All rights reserved.

  • Terms of Use
  • Privacy
  • Sitemap
  • Contact